Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 374794-96-4 | MDL No. : | MFCD11042295 |
Formula : | C13H23NO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | JHFMRJOXVOCJJQ-UHFFFAOYSA-N |
M.W : | 241.33 | Pubchem ID : | 21955227 |
Synonyms : |
|
Num. heavy atoms : | 17 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.92 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 69.72 |
TPSA : | 38.77 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.57 cm/s |
Log Po/w (iLOGP) : | 2.99 |
Log Po/w (XLOGP3) : | 1.7 |
Log Po/w (WLOGP) : | 2.04 |
Log Po/w (MLOGP) : | 1.71 |
Log Po/w (SILICOS-IT) : | 1.89 |
Consensus Log Po/w : | 2.07 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.21 |
Solubility : | 1.49 mg/ml ; 0.00618 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.13 |
Solubility : | 1.79 mg/ml ; 0.00742 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.07 |
Solubility : | 2.05 mg/ml ; 0.00851 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.93 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
65% | With triphenylphosphine; diethylazodicarboxylate In tetrahydrofuran at 0 - 20℃; | Diethyl azodicarboxylate (183 μl, 1.16 mmol) in tetrahydrofuran (0.5 mL) was added dropwise to a stirred, cooled (0° C.) solution of 1,1-dimethylethyl 4-(2-hydroxyethyl)-4-(hydroxymethyl)-1-piperidinecarboxylate (Description 42, 250 mg, 0.96 mmol) and triphenylphosphine (303 mg, 1.16 mmol) in tetrahydrofuran (10 mL) and the mixture was stirred at 020 C. for 90 minutes then at room temperature overnight. The mixture was cooled to 020 C. and further triphenylphosphine (126 mg, 0.48 mmol) and diethyl azodicarboxylate (76 μl, 0.48 mmol) were added. The mixture was stirred at room temperature for 2.5 hours, then the solvent was evaporated under reduced pressure and the residue was purified by flash column chromatography on silica gel, eluting with isohexane/EtOAc (80:20), to give the title compound as a colorless oil (150 mg, 65percent). m/z (ES+) 186 (M+1-C4H8). |
65% | at 0 - 20℃; | Diethyl azodicarboxylate (183 μl, 1.16 mmol) in tetrahydrofuran (0.5 mL) was added dropwise to a stirred, cooled (0° C.) solution of 1,1-methylethyl 4(2-hydroxyethyl)-4-(hydroxymethyl)-1-piperidinecarboxylate (Description 84, 250 mg, 0.96 mmol) and triphenylphosphine (303 mg, 1.16 mmol) in tetrahydrofuran (10 mL) and the mixture was stirred at 0° C. for 90 minutes then at room temperature overnight. The mixture was cooled to 0° C. and further triphenylphosphine (126 mg, 0.48 mmol) and diethyl azodicarboxylate (76 μl, 0.48 mmol) were added. The mixture was stirred at room temperature for 2.5 hours, then the solvent was evaporated under reduced pressure and the residue was purified by flash column chromatography on silica gel, eluting with 4:1 isohexane:ethyl acetate, to give the title compound as a colorless oil (150 mg, 65percent). m/z (ES+) 186 (M+1-C4H8). |
[ 1260099-72-6 ]
tert-Butyl 4-((2-hydroxyethoxy)methyl)piperidine-1-carboxylate
Similarity: 0.96
[ 240401-27-8 ]
tert-Butyl 2-oxa-7-azaspiro[3.5]nonane-7-carboxylate
Similarity: 0.94
[ 236406-21-6 ]
1-Boc-4-(Hydroxymethyl)-4-methylpiperidine
Similarity: 0.94
[ 123855-51-6 ]
tert-Butyl 4-(hydroxymethyl)piperidine-1-carboxylate
Similarity: 0.94
[ 1260099-72-6 ]
tert-Butyl 4-((2-hydroxyethoxy)methyl)piperidine-1-carboxylate
Similarity: 0.96
[ 240401-27-8 ]
tert-Butyl 2-oxa-7-azaspiro[3.5]nonane-7-carboxylate
Similarity: 0.94
[ 236406-21-6 ]
1-Boc-4-(Hydroxymethyl)-4-methylpiperidine
Similarity: 0.94
[ 123855-51-6 ]
tert-Butyl 4-(hydroxymethyl)piperidine-1-carboxylate
Similarity: 0.94
[ 1260099-72-6 ]
tert-Butyl 4-((2-hydroxyethoxy)methyl)piperidine-1-carboxylate
Similarity: 0.96
[ 240401-27-8 ]
tert-Butyl 2-oxa-7-azaspiro[3.5]nonane-7-carboxylate
Similarity: 0.94
[ 236406-21-6 ]
1-Boc-4-(Hydroxymethyl)-4-methylpiperidine
Similarity: 0.94
[ 123855-51-6 ]
tert-Butyl 4-(hydroxymethyl)piperidine-1-carboxylate
Similarity: 0.94
[ 240401-27-8 ]
tert-Butyl 2-oxa-7-azaspiro[3.5]nonane-7-carboxylate
Similarity: 0.94
[ 147804-30-6 ]
tert-Butyl 1-oxa-6-azaspiro[2.5]octane-6-carboxylate
Similarity: 0.91
[ 173405-78-2 ]
tert-Butyl 3,9-diazaspiro[5.5]undecane-3-carboxylate
Similarity: 0.90
[ 240401-09-6 ]
tert-Butyl 3-hydroxy-1-oxa-8-azaspiro[4.5]decane-8-carboxylate
Similarity: 0.89
[ 189333-03-7 ]
tert-Butyl 2,9-diazaspiro[5.5]undecane-2-carboxylate
Similarity: 0.88
[ 240401-09-6 ]
tert-Butyl 3-hydroxy-1-oxa-8-azaspiro[4.5]decane-8-carboxylate
Similarity: 0.89
[ 954236-44-3 ]
tert-Butyl 3-oxo-1-oxa-8-azaspiro[4.5]decane-8-carboxylate
Similarity: 0.80
[ 1408075-90-0 ]
tert-Butyl 7-oxo-5-oxa-2-azaspiro[3.4]octane-2-carboxylate
Similarity: 0.71
[ 104227-71-6 ]
(S)-tert-Butyl (5-oxotetrahydrofuran-3-yl)carbamate
Similarity: 0.63
[ 374794-92-0 ]
1-Oxa-8-azaspiro[4.5]decan-2-one hydrochloride
Similarity: 0.56